We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
-14.04%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$627M
AUM Growth
+$7.4M
(+1.2%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
20.01%
Top 10 Holdings %
Top 10 Hldgs %
49.49%
Holding
67
New
8
Increased
17
Reduced
20
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
|
+$30.1M |
| 2 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$14.9M |
| 3 |
Nektar Therapeutics
NKTR
|
+$14.4M |
| 4 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$14.3M |
| 5 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$22.2M |
| 2 |
SHPG
Shire pic
SHPG
|
+$11.4M |
| 3 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$7.93M |
| 4 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$4.51M |
| 5 |
DVAX
Dynavax Technologies
DVAX
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 75.2% |
| 2 | Communication Services | 3.64% |
| 3 | Energy | 0.8% |
| 4 | Financials | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Merck
MRK
$322B
| $328K | 0.05% |
4,500
| – | – |
|
|
DYNT
52
DELISTED
Dynatronics Corp
DYNT
| $308K | 0.05% |
22,541
+379
| +2% | +$5.18K |
|
53
Novartis
NVS
$297B
| $307K | 0.05% |
3,986
| – | – |
|
54
Sanofi
SNY
$103B
| $292K | 0.05% |
6,720
| – | – |
|
55
Johnson & Johnson
JNJ
$618B
| $282K | 0.05% |
2,183
| – | – |
|
56
Amgen
AMGN
$208B
| $215K | 0.03% |
1,105
| – | – |
|
57
Elevance Health
ELV
$81.5B
| $211K | 0.03% |
803
| – | – |
|
58
Teleflex
TFX
$6.05B
| $202K | 0.03% |
783
| – | – |
|
59
HCA Healthcare
HCA
$87.2B
| – | – |
-1,513
| Closed | -$210K |
|
60
Revvity
RVTY
$12.6B
| – | – |
-2,270
| Closed | -$221K |
|
|
SGMO
61
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| – | – |
-265,877
| Closed | -$4.51M |
|
|
STRM
62
DELISTED
Streamline Health Solutions
STRM
| – | – |
-2,647
| Closed | -$47K |
|
63
Catheter Precision
VTAK
$906K
| – | – |
0
| – | -$1.09M |
|
|
ENZ
64
DELISTED
Enzo Biochem, Inc.
ENZ
| – | – |
-188,159
| Closed | -$775K |
|
|
HRC
65
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| – | – |
-2,144
| Closed | -$202K |
|
|
KTWO
66
DELISTED
K2M Group Holdings, Inc
KTWO
| – | – |
-289,756
| Closed | -$7.93M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, First Light Asset Management held 67 positions worth $627M, up 1.2% from $620M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
First Light Asset Management deployed $125M of net new capital in Q4 2018, opening 8 new positions and adding to 17 existing holdings. Its largest new stake was SeaSpine Holdings Corporation Common Stock: 1,785,071 shares worth $32.6M.
By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 84% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was NeoGenomics, an estimated $22.2M trimmed.
- First Light Asset Management's largest Q4 2018 buy was SeaSpine Holdings Corporation Common Stock: 1,785,071 shares worth $32.6M.
- First Light Asset Management added most to Nuvectra Corporation Common Stock in Q4 2018, an estimated $14.9M increase.
- First Light Asset Management's biggest Q4 2018 reduction was NeoGenomics, cutting an estimated $22.2M.
- First Light Asset Management fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $7.93M.
- First Light Asset Management's ten largest holdings make up 49% of its $627M portfolio in Q4 2018.
- First Light Asset Management opened 8 new positions and closed 7 in Q4 2018.
- First Light Asset Management's portfolio value rose 1.2% quarter-over-quarter to $627M.
Based on First Light Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.